Details

<p><i>Contributors, vii</i></p> <p><i>Preface, x</i></p> <p><b>1 Prostate Cancer Epidemiology, 1</b><br /> <i>Annie Darves-Bornoz, Joe Park, and Aaron Katz</i></p> <p><b>2 Diagnosis and Screening, 16</b><br /> <i>Yiannis Philippou, Harveer Dev, and Prasanna Sooriakumaran</i></p> <p><b>3 Understanding the Histopathology, 34</b><br /> <i>Jon Oxley</i></p> <p><b>4 Markers in Prostate Cancer, 49</b><br /> <i>Philippa J. Cheetham</i></p> <p><b>5 Imaging, 72</b><br /> <i>Jonathan Richenberg</i></p> <p><b>6 Counseling the Patient with Newly Diagnosed Prostate Cancer, Stage by Stage, 116</b><br /> <i>Nicholas James Smith and William Richard Cross</i></p> <p><b>7 Active Surveillance in the Management of Low-Risk Prostate Cancer, 136</b><br /> <i>L. Boccon-Gibod</i></p> <p><b>8 Radical Surgery, 145</b><br /> <i>Adnan Ali and Ashutosh Tewari</i></p> <p><b>9 Radiation Therapy in the Management of Prostate Cancer, 170</b><br /> <i>J. Conibear and P.J. Hoskin</i></p> <p><b>10 Novel Therapies for Localized Prostate Cancer, 191</b><br /> <i>Massimo Valerio, Mark Emberton, Manit Arya, and Hashim U. Ahmed</i></p> <p><b>11 Posttherapy Follow-up and First Intervention, 211</b><br /> <i>Ernesto R. Cordeiro, Anastasios Anastasiadis, Matias Westendarp, Jean J.M.C.H. de la Rosette, and Theo M. de Reijke</i></p> <p><b>12 Managing Rising PSA in Naive and Posttherapy Patients, 230</b><br /> <i>George Thalmann and Martin Spahn</i></p> <p><b>13 Diagnosis and Management of Metastatic Prostate Cancer, 245</b><br /> <i>Bertrand Tombal and Frederic Lecouvet</i></p> <p><b>14 New Therapies in Hormone Relapsed Disease, 265</b><br /> <i>Carmel Pezaro, Aurelius Omlin, Diletta Bianchini, and Johann de Bono</i></p> <p><b>15 End of Life Care in Prostate Cancer, 287</b><br /> <i>John D. Graham</i></p> <p><b>16 The Long Perspective: Prostate Cancer as a Chronic Disease, 298</b><br /> <i>Peter Whelan</i></p> <p><b>17 The Future: What’s in the Toolkit for Prostate Cancer Diagnosis and Treatment?, 313</b><br /> <i>Norman J. Maitland</i></p> <p><i>Index, 331</i></p> <p><b>Color plate section can be found facing page 148</b></p>

<p><b>Ashutosh K. Tewari,</b> M.D., M. Ch. Ronald P. Lynch Professor of Urologic-<br /> Oncology; Director, Center for Prostate Cancer, Weill Cornell Medical College<br /> and New York Presbyterian Hospital, New York, USA</p> <p><b>Peter Whelan</b>, MS,FRCS, Emeritus Consultant Urological Surgeon, St. James’s<br /> University Hospital, Leeds, and Community NHS Urologist, Leeds, UK</p> <p><b>John D. Graham</b>, FRCP, FRCR, Consultant in Clinical Oncology, Beacon<br /> Centre, Musgrove Park Hospital, Taunton, Somerset, UK</p>

<p><b><i>Do you manage patients with prostate cancer? </i></b></p> <p><b><i>Could you use an expert guide examining all possible management options?</i></b></p> <p><i>Prostate Cancer: diagnosis and clinical management</i> providesurologists and oncologists of all levels with up-to-date, evidence-based guidance to the diagnosis, treatment and clinical management of a disease which accounts for a quarter of all cancers affecting men.</p> <p>Designed to be as practical and accessible as possible, leading experts discuss key issues in prostate cancer management and examine how to deliver best practice in the clinical care of their patients.  Topics covered include:</p> <ul> <li>What must be considered when counseling newly-diagnosed cancer patients</li> <li>Radical surgery options for prostate cancer</li> <li>Novel therapies for localized prostate cancer</li> <li>How should metastatic prostate cancer be diagnostic and managed</li> <li>What are the best methods of administering end of life care for the patient</li> </ul> <p>Brought to you by a highly experienced editor team, and containing key points, management algorithms, practice tips and the latest AUA and EAU clinical guidelines, this is the ideal consultation tool for doctors both on the wards and in the office.</p>

GB